Budesonide Market Forecast With Insights On Demand And Industry Growth

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Budesonide Market From 2026 To 2030?

The budesonide market size has exhibited robust growth over recent years. It is projected to expand from $10.26 billion in 2025 to $10.88 billion in 2026, indicating a compound annual growth rate (CAGR) of 6.0%. The increase observed during the historical period can be attributed to factors such as the rising prevalence of asthma and COPD, the widespread adoption of corticosteroids, the expansion of inhalation therapies, an increase in IBD diagnoses, and improvements in drug delivery technologies.

The budesonide market size is anticipated to undergo significant growth in the coming years. It is projected to expand to $13.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period is attributable to an aging population, the escalation of chronic inflammatory diseases, an increase in generic drug usage, the proliferation of home-based therapies, and a rising burden of respiratory illnesses. Prominent trends for the forecast period encompass the increasing deployment of inhaled corticosteroids in chronic respiratory care, a greater uptake in inflammatory bowel disease management, a developing preference for targeted localized steroid therapy, the broadening of generic budesonide formulations, and an expanded role in long-term maintenance therapy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21121&type=smp

What Major Factors Are Driving The Budesonide Market Forward?

The rising occurrence of respiratory conditions is projected to stimulate the expansion of the budesonide market moving forward. These medical conditions involve organs and tissues vital for gas exchange in air-breathing creatures. The surge in respiratory disease prevalence stems from increasing air pollution, specifically exposure to particulate matter and allergens, which significantly influences the rates of asthma and chronic obstructive lung disease. Budesonide is administered for respiratory ailments such as asthma and chronic obstructive pulmonary disease (COPD) to alleviate inflammation, enhance airflow, and prevent symptoms like wheezing and breathlessness. As an illustration, in August 2025, the Centers for Disease Control and Prevention, a Switzerland-based public health agency, reported that 90% of the nation’s 4.9 trillion dollars in annual health care spending is allocated to individuals with chronic and mental health conditions, with over 84,000 Americans dying each year from heart disease or stroke and cardiovascular disease costs estimated to reach approximately 2 trillion dollars by 2050. Consequently, the increasing prevalence of respiratory diseases will fuel the growth of the budesonide market.

Which Segment Categories Are Included In The Budesonide Market Segment Analysis?

The budesonide market covered in this report is segmented –

1) By Type: Inhalation Powder, Aerosols, Tablets And Capsules

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Respiratory Disease Treatment, Other Applications

Subsegments:

1) By Inhalation Powder: Dry Powder Inhalers (DPI), Soft Mist Inhalers (SMI)

2) By Aerosols: Metered-Dose Inhalers (MDI), Breath-Activated Inhalers

3) By Tablets And Capsules: Oral Tablets, Oral Capsules

What Market Trends Are Affecting The Budesonide Market?

Leading firms within the budesonide market are prioritizing innovations in respiratory care, particularly oral therapy, to boost patient convenience, ensure better treatment compliance, and broaden the range of available therapies for asthma and various other respiratory ailments. This oral budesonide therapy involves a specific preparation of budesonide administered orally, predominantly employed in addressing inflammatory conditions. An illustrative event occurred in February 2024 when Takeda Pharmaceuticals, a pharmaceutical company based in Japan, disclosed that the Food and Drug Administration (FDA), a US federal agency, had granted authorization for EOHILIA, an oral suspension of budesonide. This marked its status as the inaugural and sole FDA-approved oral drug for individuals aged 11 and older suffering from eosinophilic esophagitis (EoE). Furthermore, the FDA’s approval for EOHILIA, prescribed at 2 mg twice daily, was grounded in efficacy and safety findings from two multicenter, randomized, double-blind, parallel-group, placebo-controlled investigations, each lasting 12 weeks, involving patients with EoE ranging from 11 to 56 years old.

Who Are The Active Companies Shaping The Budesonide Market?

Major companies operating in the budesonide market are AstraZeneca AB, Novartis AG, Takeda Pharmaceuticals Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz AG, Aurobindo Pharma Limited, Chiesi Farmaceutici S.p.A., Cipla Limited, Lupin Limited, Orion Corporation, Salix Pharmaceuticals Inc., Synmosa Biopharma Corporation, Cosmo Pharmaceuticals N.V., Skyepharma Holdings Inc., Manus Aktteva Biopharma LLP, Cennet Biopharma Private Limited, Santarus Inc., SiNi Pharma Private Limited, Shanghai Sine Promod Pharmaceutical Co. Ltd.

Get The Full Budesonide Market Report:

https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report

Where Is The Budesonide Market Primarily Concentrated By Region?

North America was the largest region in the budesonide market in 2025. The regions covered in the budesonide market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Budesonide Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/budesonide-global-market-report

Browse Through More Reports Similar to the Global Budesonide Market 2026, By The Business Research Company

Cannabis Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report

Tea Capsule Market Report 2026

https://www.thebusinessresearchcompany.com/report/tea-capsule-global-market-report

Cannabis Extract Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795